Effect of diltiazem slow-release formulation on silent myocardial ischemia in stable coronary artery disease
- 6 March 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 69 (7) , B30-B35
- https://doi.org/10.1016/0002-9149(92)91347-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of nifedipine on total ischemic activity and circadian distribution of myocardial ischemic episodes in angina pectorisThe American Journal of Cardiology, 1991
- Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.Circulation, 1990
- Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease.Circulation, 1989
- Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: Effects on total ischemic activity and heart rate at onset of ischemiaAmerican Heart Journal, 1988
- Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.Circulation, 1988
- Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery diseaseThe American Journal of Cardiology, 1987
- A single-blind, placebo-controlled study of effects of atenolol on transient ischemia in “mixed” anginaThe American Journal of Cardiology, 1987
- Effect of propranolol on indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory st-segment monitoringClinical Cardiology, 1986
- Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.Heart, 1985
- Nifedipine and propranolol: A beneficial drug interactionThe American Journal of Medicine, 1981